hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 14:58:07 - browse：938

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Patients' immediate access to test results puts radiologists in a bind

WSS

Brain MRIs reveal impact of 'toxic stress' on Black children

FDA approves world's first CRISPR

BIO to announce reorganization, senior leaders expected to depart

The effects of a landmark ruling on DNA ownership are becoming clearer

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Crowdfunding for medical bills sidesteps core problem, author says

Wikipedia

hotspot

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

The creative science of coining drug names

Virginia high school admissions case could be legal follow

The creative science of coining drug names

United colonoscopy coverage change 'may cost lives,' doctors say

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Peter Hotez and the public health issue of online harassment

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Walensky prepares to leave CDC — and Congress — behind

Pharma patents targeted by Biden in move to slash drug prices

focus

Crowdfunding for medical bills sidesteps core problem, author says

Warren pushes Witty on UnitedHealth's control over physicians

Pfizer plans to depart BIO

Pharma patents targeted by Biden in move to slash drug prices

AI for drug discovery: Experts on separating hype from reality

What PEPFAR has meant on the ground in Ukraine

knowledge

focus

hotspot

explore